Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-04-08

FDA Approved: AMLODIPINE BESYLATE — Original Application (Epic Pharma, LLC)

View source ↗

Summary

The FDA approved the original application for amlodipine besylate from Epic Pharma, LLC, enabling its generic version of the calcium channel blocker. It is indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

ORIG AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)